ADPT
Adaptive Biotechnologies Corp. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website adaptivebiotech.com
- Employees(FY) 790
- ISIN US00650F1093
Performance
+20.25%
1W
+7.58%
1M
+38.9%
3M
+87.14%
6M
+18.78%
YTD
+29.05%
1Y
Profile
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer and autoimmune disorders. It offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Technical Analysis of ADPT 2024-11-08
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-09 08:52
- 2024-11-08 10:18
Q3 2024 Adaptive Biotechnologies Corp Earnings Call(Thomson Reuters StreetEvents)
- 2024-11-08 02:29
- 2024-11-07 18:30
- 2024-11-07 18:15
- 2024-11-07 17:11
Adaptive Biotechnologies: Q3 Earnings Snapshot(Associated Press Finance)
- 2024-11-07 16:05
- 2024-11-07 07:30
- 2024-11-06 18:30
- 2024-11-06 07:28
- 2024-11-01 09:09
November 2024's Top US Penny Stocks With Growth Potential(Simply Wall St.)
- 2024-10-09 16:05
- 2024-10-09 04:05
- 2024-10-07 09:40
- 2024-10-04 04:35
Parametric company Adaptive Insurance launches operations(Life Insurance International)
- 2024-08-29 09:40
- 2024-08-29 07:30
- 2024-08-28 19:30
- 2024-08-22 16:03
- 2024-08-22 04:03
- 2024-08-01 19:00
- 2024-08-01 18:20
- 2024-08-01 17:23
Adaptive Biotechnologies: Q2 Earnings Snapshot(Associated Press Finance)
- 2024-08-01 16:05
- 2024-08-01 04:05
- 2024-07-29 10:17
- 2024-07-21 06:00
3 Precision Medicine Stocks Tailoring Treatments(InvestorPlace)
- 2024-07-20 18:00
3 Precision Medicine Stocks Tailoring Treatments(Investorplace)
- 2024-07-15 12:00
- 2024-07-11 16:05
Page 1 of 7
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.